Globe Life Inc. $GL Position Lifted by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its stake in Globe Life Inc. (NYSE:GL) by 11.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 247,947 shares of the company’s stock after purchasing an additional 24,785 shares during the period. JPMorgan Chase & Co. owned 0.31% of Globe Life worth $35,449,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Mather Group LLC. bought a new stake in Globe Life in the third quarter valued at about $28,000. CYBER HORNET ETFs LLC bought a new position in Globe Life during the 2nd quarter worth approximately $28,000. MUFG Securities EMEA plc bought a new position in Globe Life during the 2nd quarter worth approximately $31,000. Quent Capital LLC acquired a new position in shares of Globe Life in the 3rd quarter worth approximately $36,000. Finally, AlphaCore Capital LLC grew its position in shares of Globe Life by 1,557.1% in the 2nd quarter. AlphaCore Capital LLC now owns 348 shares of the company’s stock worth $43,000 after acquiring an additional 327 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Stock Down 0.6%

Shares of Globe Life stock opened at $136.85 on Monday. The stock has a market capitalization of $10.73 billion, a price-to-earnings ratio of 9.72 and a beta of 0.46. Globe Life Inc. has a twelve month low of $109.38 and a twelve month high of $152.71. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. The business’s 50 day simple moving average is $141.82 and its 200-day simple moving average is $138.94.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the firm earned $3.14 EPS. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 1.0%. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life’s dividend payout ratio is presently 7.67%.

Analyst Ratings Changes

Several research firms recently issued reports on GL. TD Cowen reissued a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Wells Fargo & Company lifted their price objective on shares of Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a report on Wednesday, February 25th. Morgan Stanley reiterated an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. JPMorgan Chase & Co. increased their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Finally, Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $171.33.

Insider Buying and Selling at Globe Life

In related news, CEO James Matthew Darden sold 18,318 shares of Globe Life stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total value of $2,657,941.80. Following the sale, the chief executive officer directly owned 51,093 shares in the company, valued at $7,413,594.30. This trade represents a 26.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the transaction, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,192,969.04. The trade was a 25.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 82,807 shares of company stock valued at $12,041,286. Corporate insiders own 1.97% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.